NCT01644929

Brief Summary

Rehabilitation after stroke improves motor functions by promoting plastic changes however, after completing standard rehabilitation, 50-60% of patients still exhibit some degree of motor impairment and require at least partial assistance in activities of day living. Therefore, the exploration of other approaches to promote recovery is compulsory. Non invasive brain stimulation and motor rehabilitation are thought to share similar mechanisms in inducing neuroplastic changes in the human cortex and an emerging field of research is focusing on the possibility of coupling both therapies in order to achieve an additive effect and improve outcome. We hypothesize that coupling bihemispheric transcranial direct current stimulation (tDCS) with simultaneous physical/occupational therapy in the subacute phase of ischemic stroke patients may improve upper limb motor recovery in humans. This is a randomized, controlled, double blind, cross-over, multicentre, clinical trial. Thirty-six ischemic stroke patients in the subacute phase will be recruited in three centers of neurorehabilitation in Switzerland. After stratification based on the Fugl-Meyer Assessment Upper Extremity according to the severity of the deficit, the patient will be randomized to receive besides standardized physical/occupational treatment according to the Impairment-Oriented Training, tDCS of themotor cortex (1.5 mA, 30 minutes) (group 1: 12 patients) or sham stimulation (without current) (group 2: 12 patients). After three weeks of treatment group 1 and 2 will cross-over and will be treated for other three weeks. Group 3 (12 patients) will receive routine physical/occupational treatment and sham tDCS for six weeks. Assessment will be performed before starting tDCS, at week 3, 6 and at 6 months. Outcome measures are the Fugl-Meyer Assessment Upper Extremity, the extended Barthel Index, the Ashworth scale, the Test of Upper Limb Apraxia (only baseline, week 6, month6), the grip strength evaluated by the Jamar Hydraulic Hand dynamometer. At baseline at week 6 and at month 6 depression will be assessed by the Hamilton depression Rating Scale.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 17, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 19, 2012

Completed
8 months until next milestone

Study Start

First participant enrolled

March 1, 2013

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2018

Completed
Last Updated

September 19, 2017

Status Verified

September 1, 2017

Enrollment Period

4.9 years

First QC Date

July 17, 2012

Last Update Submit

September 18, 2017

Conditions

Keywords

hemiparesisbihemispheric transcranial direct current stimulationischemic strokesubacuterehabilitationphysiotherapyergotherapy

Outcome Measures

Primary Outcomes (1)

  • Fugl-Meyer Assessment Upper Extremity

    Investigator administered questionnaire

    6 weeks

Secondary Outcomes (15)

  • Fugl-Meyer Assessment Upper Extremity

    3 weeks

  • Fugl-Meyer Assessment Upper Extremity

    6 months

  • Barthel Index

    3 weeks

  • Barthel Index

    6 weeks

  • Barthel Index

    6 months

  • +10 more secondary outcomes

Study Arms (3)

1 tDCS-Sham

EXPERIMENTAL

tDC stimulation for 3 weeks, then cross-over to sham stimulation

Procedure: transcranial direct current stimulation (tDCS)

2 Sham-tDCS

EXPERIMENTAL

Sham stimulation for 3 weeks, then cross over to tDCS stimulation

Procedure: Sham stimulation, then tDCS

3 Sham-Sham

SHAM COMPARATOR

Treatment for 6 weeks daily with sham stimulation

Procedure: Sham stimulation

Interventions

Anodal tDCS of the ipsilesional motor cortex and cathodal tDCS of contralesional motor cortex (1.5 mA, 30 minutes) for 15 days during three weeks, then sham stimulation for 30 seconds on 15 days during 3 weeks

1 tDCS-Sham

Sham stimulation for 30 seconds on 15 days during 3 weeks, then anodal tDCS of the ipsilesional motor cortex and cathodal tDCS of contralesional motor cortex (1.5 mA, 30 minutes) for 15 days during three weeks

2 Sham-tDCS

Sham stimulation for 30 seconds on 15 days during 6 weeks

3 Sham-Sham

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ischemic lesions in the territory of middle cerebral artery subcortical or subcortical/cortical confirmed neuroimaging
  • Persistent hemiparesis, indicated by a score of 1-3 on the motor arm item of the NIH Stroke Scale (NIHSS) (Brott et al. 1989) but wrist and finger movement is not required
  • No UE injury or conditions that limited use prior to the stroke.
  • The patient is \>18 years old.
  • The patient has subscribed the informed consent

You may not qualify if:

  • History of epilepsy, brain tumor, major head trauma, learning disorder, severe cognitive impairment, drug or alcohol abuse, major psychiatric illness
  • Use of medications that may lower seizure threshold (e.g., metronidazole, fluoroquinolones)
  • Severe pain in the affected upper limb (\>=8 on the shoulder item of the "joint pain during passive motion" of the Fugl-Meyer Assessment Upper Extremity)
  • Further stroke or other significant medical complication during the study
  • Evidence of severe leucoencephalopathy (grade IV according to the Fazeka's scale)
  • Important aphasia that would impair the understanding and performance of the assessment scales

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Universitätsspital Bern, Inselspital, Neuropsychologische Rehabilitation

Bern, 3010, Switzerland

WITHDRAWN

Clinica Hildebrand, Centro di riabilitazione Brissago

Brissago, 6614, Switzerland

RECRUITING

HELIOS Klinik Zihlschlacht AG, Neurologisches Rehabilitationszentrum

Zihlschlacht, 8588, Switzerland

TERMINATED

Related Publications (2)

  • Lindenberg R, Renga V, Zhu LL, Nair D, Schlaug G. Bihemispheric brain stimulation facilitates motor recovery in chronic stroke patients. Neurology. 2010 Dec 14;75(24):2176-84. doi: 10.1212/WNL.0b013e318202013a. Epub 2010 Nov 10.

    PMID: 21068427BACKGROUND
  • Elsner B, Kugler J, Pohl M, Mehrholz J. Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke. Cochrane Database Syst Rev. 2020 Nov 11;11(11):CD009645. doi: 10.1002/14651858.CD009645.pub4.

Related Links

MeSH Terms

Conditions

Ischemic StrokeParesis

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Carlo Cereda, MD

    Ospedale Regionale di Lugano - Civico

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Capo clinica

Study Record Dates

First Submitted

July 17, 2012

First Posted

July 19, 2012

Study Start

March 1, 2013

Primary Completion

February 1, 2018

Study Completion

February 1, 2018

Last Updated

September 19, 2017

Record last verified: 2017-09

Locations